United States Biotechnology & Medical Research

ESSA Pharma Inc (EPIX)

Track

Track

Ticker: EPIX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ESSA Pharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
176.93
Quantity 1,608 +13.7%
Value US$3,450,879
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
40.65
Quantity 45,734 -35.8%
Value US$314,651
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
299.21
Quantity 14,069 +21.5%
Value US$1,550,061
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Sale
Price
1.51
Quantity 1,879,583 -100.0%
Value US$2,843,809
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Sale
Price
1.53
Quantity 2,000,000 -51.6%
Value US$3,058,800
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Sale
Price
1.53
Quantity 2,000,000 -34.0%
Value US$3,051,800
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Sale
Price
1.53
Quantity 2,000,000 -25.4%
Value US$3,064,000
Virsik, Peter Director of Issuer Non-Executive Director
Transaction date
Planned sale
Price
6.03
Quantity 694 -8.2%
Value US$4,185
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
6.03
Quantity 694 -8.2%
Value US$4,185
Virsik, Peter Director of Issuer Non-Executive Director
Transaction date
Planned sale
Price
6.00
Quantity 694 -7.6%
Value US$4,164
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
6.00
Quantity 694 -7.6%
Value US$4,164
Virsik Peter Officer Officer
Transaction date
Proposed sale
Price
5.59
Quantity 4,164
Value US$23,277
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
6.03
Quantity 2,082 -18.5%
Value US$12,554
Virsik, Peter Director of Issuer Non-Executive Director
Transaction date
Planned sale
Price
6.03
Quantity 2,082 -18.5%
Value US$12,554
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
6.95
Quantity 694 -5.8%
Value US$4,823
Virsik Peter Officer Officer
Transaction date
Proposed sale
Price
8.16
Quantity 2,082
Value US$16,989
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
7.94
Quantity 694 -5.5%
Value US$5,510
Virsik, Peter Director of Issuer Non-Executive Director
Transaction date
Planned sale
Price
7.94
Quantity 694 -5.5%
Value US$5,510
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
8.98
Quantity 694 -5.2%
Value US$6,232
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
10.29
Quantity 72,782 -84.5%
Value US$748,927
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
10.04
Quantity 500 -3.6%
Value US$5,020
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
9.25
Quantity 694 -4.9%
Value US$6,420
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
10.01
Quantity 1,718 -10.9%
Value US$17,197
Virsik Peter Officer Officer
Transaction date
Proposed sale
Price
9.94
Quantity 75,000
Value US$745,500
Virsik, Peter Director of Issuer Non-Executive Director
Transaction date
Planned sale
Price
6.11
Quantity 699 -4.7%
Value US$4,271
Virsik Peter Chief Operating Officer Officer
Transaction date
Planned sale
Price
6.11
Quantity 699 -4.7%
Value US$4,271
Virsik Peter Officer Officer
Transaction date
Proposed sale
Price
6.17
Quantity 2,087
Value US$12,877
3.2
Parkinson, David Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.30
Quantity 9,223 +16.3%
Value US$21,250
3.2
Parkinson David Ross Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
2.30
Quantity 9,223 +16.3%
Value US$21,213
3.4
BERGER, FRANKLIN MILAN Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
5.73
Quantity 23,529 +3.1%
Value US$134,821
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
5.73
Quantity 23,259 +3.1%
Value US$133,274
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
5.99
Quantity 16,471 +2.2%
Value US$98,661
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
5.35
Quantity 60,000 +8.8%
Value US$321,000
Wood, David Sidney Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
2.60
Quantity 8,302 +33.2%
Value US$21,585
3.2
Parkinson, David Director of Issuer Non-Executive Director
Transaction date
Planned purchase
Price
2.60
Quantity 3,067 +5.7%
Value US$7,974
3.2
Parkinson David Ross Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
2.60
Quantity 3,067 +5.7%
Value US$7,974
Wood David S. Chief Financial Officer Officer
Transaction date
Planned purchase
Price
2.60
Quantity 8,302 +33.2%
Value US$21,585
3.2
Parkinson, David Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.39
Quantity 21,367 +66.5%
Value US$51,067
3.2
Parkinson David Ross Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.39
Quantity 21,367 +66.5%
Value US$51,067
3.4
BERGER, FRANKLIN MILAN Director of Issuer Non-Executive Director
Transaction date
Sale
Price
2.42
Quantity 34,334 -4.8%
Value US$83,088
3.4
BERGER, FRANKLIN MILAN Director of Issuer Non-Executive Director
Transaction date
Sale
Price
2.41
Quantity 37,889 -5.0%
Value US$91,312
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Sale
Price
2.42
Quantity 34,334 -4.8%
Value US$83,088
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Sale
Price
2.41
Quantity 37,889 -5.0%
Value US$91,312
3.4
BERGER, FRANKLIN MILAN Director of Issuer Non-Executive Director
Transaction date
Sale
Price
2.53
Quantity 43,617 -5.5%
Value US$110,351
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Sale
Price
2.53
Quantity 43,617 -5.5%
Value US$110,351
3.4
BERGER, FRANKLIN MILAN Director of Issuer Non-Executive Director
Transaction date
Sale
Price
2.67
Quantity 50,000 -5.9%
Value US$133,500
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Sale
Price
2.67
Quantity 50,000 -5.9%
Value US$133,500
3.4
BERGER, FRANKLIN MILAN Director of Issuer Non-Executive Director
Transaction date
Sale
Price
2.86
Quantity 50,000 -5.6%
Value US$143,000
3.4
BERGER, FRANKLIN MILAN Director of Issuer Non-Executive Director
Transaction date
Sale
Price
2.90
Quantity 32,000 -3.4%
Value US$92,800
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Sale
Price
2.86
Quantity 50,000 -5.6%
Value US$143,000
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Sale
Price
2.90
Quantity 32,000 -3.4%
Value US$92,800
3.4
BERGER, FRANKLIN MILAN Director of Issuer Non-Executive Director
Transaction date
Sale
Price
3.00
Quantity 25,000 -2.6%
Value US$75,000
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Sale
Price
3.00
Quantity 25,000 -2.6%
Value US$75,000
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Purchase
Price
4.50
Quantity 500,000 +6.8%
Value US$2,251,100
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Purchase
Price
3.98
Quantity 1,500,000 +25.5%
Value US$5,968,500
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Purchase
Price
3.16
Quantity 300,000 +5.4%
Value US$946,740
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Purchase
Price
3.13
Quantity 241,665 +4.5%
Value US$756,798
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Purchase
Price
2.79
Quantity 347,204 +7.0%
Value US$969,428
2.3
BVF Partners L.P. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
2.66
Quantity 72,076 +62.8%
Value US$191,722
2.3
BVF Partners L.P. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
2.66
Quantity 210,176 +142.7%
Value US$559,068
2.3
BVF Partners L.P. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
2.66
Quantity 2,226,446 +89.6%
Value US$5,922,346
2.3
BVF Partners L.P. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
2.66
Quantity 1,791,302 +105.3%
Value US$4,764,863
3.2
Parkinson, David Director of Issuer Non-Executive Director
Transaction date
Planned purchase
Price
2.96
Quantity 4,887 +18.0%
Value US$14,456
3.2
Parkinson David Ross Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.96
Quantity 4,887 +18.0%
Value US$14,456
2.1
BIOTECH GROWTH N V Large shareholder
Transaction date
Sale
Price
5.85
Quantity 25,100 -0.5%
Value US$146,925
2.3
BERGER FRANKLIN M Non-Executive Director
Transaction date
Purchase
Price
27.00
Quantity 57,000 +6.3%
Value US$1,539,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-07 2025-08-05 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
1,608 +13.7%
176.93
US$3,450,879 		1,608 +13.7% 176.93 US$3,450,879
2025-08-07 2025-08-05 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
45,734 -35.8%
40.65
US$314,651 		45,734 -35.8% 40.65 US$314,651
2025-08-07 2025-08-05 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
14,069 +21.5%
299.21
US$1,550,061 		14,069 +21.5% 299.21 US$1,550,061
2024-11-05 2024-11-01 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
1,879,583 -100.0%
1.51
US$2,843,809 		1,879,583 -100.0% 1.51 US$2,843,809
2024-11-05 2024-11-01 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
2,000,000 -51.6%
1.53
US$3,058,800 		2,000,000 -51.6% 1.53 US$3,058,800
2024-11-05 2024-11-01 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
2,000,000 -34.0%
1.53
US$3,051,800 		2,000,000 -34.0% 1.53 US$3,051,800
2024-11-05 2024-11-01 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
2,000,000 -25.4%
1.53
US$3,064,000 		2,000,000 -25.4% 1.53 US$3,064,000
2024-10-07 2024-10-07 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
694 -8.2%
6.03
US$4,185 		694 -8.2% 6.03 US$4,185
2024-10-07 2024-10-07 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -8.2%
6.03
US$4,185 		694 -8.2% 6.03 US$4,185
2024-09-09 2024-09-09 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
694 -7.6%
6.00
US$4,164 		694 -7.6% 6.00 US$4,164
2024-09-09 2024-09-09 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -7.6%
6.00
US$4,164 		694 -7.6% 6.00 US$4,164
2024-09-03 2024-09-03 PrS Proposed sale
Virsik Peter

Officer

Officer
4,164
5.59
US$23,277 		4,164 5.59 US$23,277
2024-09-03 2024-09-03 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
2,082 -18.5%
6.03
US$12,554 		2,082 -18.5% 6.03 US$12,554
2024-09-03 2024-09-03 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
2,082 -18.5%
6.03
US$12,554 		2,082 -18.5% 6.03 US$12,554
2024-05-06 2024-05-06 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -5.8%
6.95
US$4,823 		694 -5.8% 6.95 US$4,823
2024-04-05 2024-04-05 PrS Proposed sale
Virsik Peter

Officer

Officer
2,082
8.16
US$16,989 		2,082 8.16 US$16,989
2024-04-05 2024-04-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -5.5%
7.94
US$5,510 		694 -5.5% 7.94 US$5,510
2024-04-05 2024-04-05 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
694 -5.5%
7.94
US$5,510 		694 -5.5% 7.94 US$5,510
2024-03-05 2024-03-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -5.2%
8.98
US$6,232 		694 -5.2% 8.98 US$6,232
2024-02-07 2024-02-06 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
72,782 -84.5%
10.29
US$748,927 		72,782 -84.5% 10.29 US$748,927
2024-02-06 2024-02-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
500 -3.6%
10.04
US$5,020 		500 -3.6% 10.04 US$5,020
2024-02-06 2024-02-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -4.9%
9.25
US$6,420 		694 -4.9% 9.25 US$6,420
2024-01-17 2024-01-16 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
1,718 -10.9%
10.01
US$17,197 		1,718 -10.9% 10.01 US$17,197
2024-01-16 2024-01-16 PrS Proposed sale
Virsik Peter

Officer

Officer
75,000
9.94
US$745,500 		75,000 9.94 US$745,500
2024-01-11 2024-01-05 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
699 -4.7%
6.11
US$4,271 		699 -4.7% 6.11 US$4,271
2024-01-08 2024-01-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
699 -4.7%
6.11
US$4,271 		699 -4.7% 6.11 US$4,271
2024-01-05 2024-01-05 PrS Proposed sale
Virsik Peter

Officer

Officer
2,087
6.17
US$12,877 		2,087 6.17 US$12,877
2023-12-18 2023-12-14 B Purchase
3.2
Parkinson, David

Director of Issuer

Non-Executive Director
9,223 +16.3%
2.30
US$21,250 		9,223 +16.3% 2.30 US$21,250
2023-12-18 2023-12-14 PP Planned purchase
3.2
Parkinson David Ross

Chief Executive Officer

Executive Director
9,223 +16.3%
2.30
US$21,213 		9,223 +16.3% 2.30 US$21,213
2023-11-22 2023-11-21 B Purchase
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
23,529 +3.1%
5.73
US$134,821 		23,529 +3.1% 5.73 US$134,821
2023-11-22 2023-11-21 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
23,259 +3.1%
5.73
US$133,274 		23,259 +3.1% 5.73 US$133,274
2023-11-16 2023-11-03 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
16,471 +2.2%
5.99
US$98,661 		16,471 +2.2% 5.99 US$98,661
2023-11-16 2023-11-02 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
60,000 +8.8%
5.35
US$321,000 		60,000 +8.8% 5.35 US$321,000
2023-01-05 2022-12-30 PP Planned purchase
Wood, David Sidney

Senior Officer of Issuer

Officer
8,302 +33.2%
2.60
US$21,585 		8,302 +33.2% 2.60 US$21,585
2023-01-05 2022-12-30 PP Planned purchase
3.2
Parkinson, David

Director of Issuer

Non-Executive Director
3,067 +5.7%
2.60
US$7,974 		3,067 +5.7% 2.60 US$7,974
2023-01-05 2022-12-30 PP Planned purchase
3.2
Parkinson David Ross

Chief Executive Officer

Executive Director
3,067 +5.7%
2.60
US$7,974 		3,067 +5.7% 2.60 US$7,974
2023-01-05 2022-12-30 PP Planned purchase
Wood David S.

Chief Financial Officer

Officer
8,302 +33.2%
2.60
US$21,585 		8,302 +33.2% 2.60 US$21,585
2023-01-05 2022-12-22 B Purchase
3.2
Parkinson, David

Director of Issuer

Non-Executive Director
21,367 +66.5%
2.39
US$51,067 		21,367 +66.5% 2.39 US$51,067
2023-01-05 2022-12-22 B Purchase
3.2
Parkinson David Ross

Chief Executive Officer

Executive Director
21,367 +66.5%
2.39
US$51,067 		21,367 +66.5% 2.39 US$51,067
2023-01-05 2022-12-21 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
34,334 -4.8%
2.42
US$83,088 		34,334 -4.8% 2.42 US$83,088
2023-01-05 2022-12-21 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
37,889 -5.0%
2.41
US$91,312 		37,889 -5.0% 2.41 US$91,312
2023-01-05 2022-12-21 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
34,334 -4.8%
2.42
US$83,088 		34,334 -4.8% 2.42 US$83,088
2023-01-05 2022-12-21 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
37,889 -5.0%
2.41
US$91,312 		37,889 -5.0% 2.41 US$91,312
2023-01-05 2022-12-20 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
43,617 -5.5%
2.53
US$110,351 		43,617 -5.5% 2.53 US$110,351
2023-01-05 2022-12-20 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
43,617 -5.5%
2.53
US$110,351 		43,617 -5.5% 2.53 US$110,351
2023-01-05 2022-12-16 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
50,000 -5.9%
2.67
US$133,500 		50,000 -5.9% 2.67 US$133,500
2023-01-05 2022-12-16 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
50,000 -5.9%
2.67
US$133,500 		50,000 -5.9% 2.67 US$133,500
2023-01-05 2022-12-15 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
50,000 -5.6%
2.86
US$143,000 		50,000 -5.6% 2.86 US$143,000
2023-01-05 2022-12-15 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
32,000 -3.4%
2.90
US$92,800 		32,000 -3.4% 2.90 US$92,800
2023-01-05 2022-12-15 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
50,000 -5.6%
2.86
US$143,000 		50,000 -5.6% 2.86 US$143,000
2023-01-05 2022-12-15 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
32,000 -3.4%
2.90
US$92,800 		32,000 -3.4% 2.90 US$92,800
2023-01-05 2022-12-14 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
25,000 -2.6%
3.00
US$75,000 		25,000 -2.6% 3.00 US$75,000
2023-01-05 2022-12-14 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
25,000 -2.6%
3.00
US$75,000 		25,000 -2.6% 3.00 US$75,000
2022-10-28 2022-10-27 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
500,000 +6.8%
4.50
US$2,251,100 		500,000 +6.8% 4.50 US$2,251,100
2022-10-28 2022-10-26 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
1,500,000 +25.5%
3.98
US$5,968,500 		1,500,000 +25.5% 3.98 US$5,968,500
2022-07-20 2022-07-18 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
300,000 +5.4%
3.16
US$946,740 		300,000 +5.4% 3.16 US$946,740
2022-07-18 2022-07-15 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
241,665 +4.5%
3.13
US$756,798 		241,665 +4.5% 3.13 US$756,798
2022-07-18 2022-07-14 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
347,204 +7.0%
2.79
US$969,428 		347,204 +7.0% 2.79 US$969,428
2022-07-15 2022-07-11 B Purchase
2.3
BVF Partners L.P.

10% Security Holder of Issuer

Large shareholder
72,076 +62.8%
2.66
US$191,722 		72,076 +62.8% 2.66 US$191,722
2022-07-15 2022-07-11 B Purchase
2.3
BVF Partners L.P.

10% Security Holder of Issuer

Large shareholder
210,176 +142.7%
2.66
US$559,068 		210,176 +142.7% 2.66 US$559,068
2022-07-15 2022-07-11 B Purchase
2.3
BVF Partners L.P.

10% Security Holder of Issuer

Large shareholder
2,226,446 +89.6%
2.66
US$5,922,346 		2,226,446 +89.6% 2.66 US$5,922,346
2022-07-15 2022-07-11 B Purchase
2.3
BVF Partners L.P.

10% Security Holder of Issuer

Large shareholder
1,791,302 +105.3%
2.66
US$4,764,863 		1,791,302 +105.3% 2.66 US$4,764,863
2022-07-05 2022-06-30 PP Planned purchase
3.2
Parkinson, David

Director of Issuer

Non-Executive Director
4,887 +18.0%
2.96
US$14,456 		4,887 +18.0% 2.96 US$14,456
2022-07-05 2022-06-30 B Purchase
3.2
Parkinson David Ross

Chief Executive Officer

Executive Director
4,887 +18.0%
2.96
US$14,456 		4,887 +18.0% 2.96 US$14,456
2022-04-28 2022-04-27 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
25,100 -0.5%
5.85
US$146,925 		25,100 -0.5% 5.85 US$146,925
2021-03-04 2021-02-22 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
57,000 +6.3%
27.00
US$1,539,000 		57,000 +6.3% 27.00 US$1,539,000
Explore more

More insider trading research around ESSA Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America